Skip to content

Why we should all be thrilled about the FDA starting to embrace innovation

March 3, 2015

On Feb. 19, the U.S. Food and Drug Administration took a huge step towards patient-centric medicine when it approved the marketing of genetics testing company 23andMe’s carrier test for Bloom…


Hopefully FDA granting permission to 23andMe to sell genetic test for one serious disease is only the beginning. I am able to handle finding out my own genetic propensities, thank you very much. Give me the information and I will decide what to do with it.

See on Scoop.itNew Space

No comments yet

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: